Figure 2From: Statistical techniques to construct assays for identifying likely responders to a treatment under evaluation from cell line genomic data Schematic of analysis procedure. We use the cell line data to construct a classifier of dacetuzumab sensitivity or ER status given gene expressions, and we subsequently apply this classifier to patient genomic data to classify these patients according to phenotype.Back to article page